Shirley, I reviewed your post with interest as I have an On-X valve, although in the five years I've had my valve it has functioned flawlessly and I have not had any problems with anemia (or any other problems, for that matter). And I am very active and work out in the gym regularly, ride my bicycle, etc., and eat primarily vegetarian food (I eat fish once or twice a week). My carnivore friends seem to always be concerned about inadequate protein intake if they switched to a vegetarian lifestyle, but it hasn't been a problem for me. However, I was interested enough to contact the On-X company and they told me the following:
1. Most cases of extreme hemolysis are caused by paravalvular leak—the seal around the valve is not complete—a small gap in between the valve sewing ring and the tissue allows regurgitation at high pressure to shear blood cells. The cause for the gap can be calcium deposits, poor tissue quality, infection and/or not enough sutures (not usually). It is rare to see the actual valve itself proven to produce clinically significant hemolysis—blood damage that requires replacement of the valve although there are a few reports of this in the surgical literature (not with the On-X valve). This can happen with tissue valves as well.
2. Paravalvular leak is not a common complication (<1%) and is usually small enough to disappear after surgery. But some are too large and cause this excess hemolysis.
3. All mechanical valves cause some level of “normal” hemolysis mainly due to turbulence within the valve structure.
They referred me to the following study from the Journal of Heart Valve Disease, Volume 9, No. 1, January 2000, pages 142 - 145. Here is the abstract:
http://www.icr-heart.com/journal/extconjan00/Examination of Hemolytic.htm
Examination of Hemolytic Potential with the On-XR Prosthetic Heart Valve
Dietrich Birnbaum MD, Axel Laczkovics MD, Martin Heidt MD, Hellmut Oelert MD,Günther Laufer MD, Hans Greve MD, Jose L. Pomar MD, Friedrich Mohr MD,Axel Haverich MD, Dieter Regensburger MD
Mechanical valves are known to produce chronic, subclinical hemolysis in most patients. The On-XR prosthetic heart valve was studied for hemolysis using standard blood parameters in isolated aortic and mitral replacement in a 10-center trial. A central clinical laboratory was used to ensure poolability of data. Results showed a decrease in serum haptoglobin and an increase in serum lactate dehydrogenase (LDH) (as is typical with mechanical prostheses). The increase was greater in mitral valve patients than aortic valve patients, but still within the normal range in most cases. Levels of blood damage for the On-X valve were lower than those reported for other mechanical valves, and hemolytic anemia did not occur with this valve.
Also this provides additional information:
www.onxlti.com/2005/01/clinical-update-thirteen/
If you want additional information you can contact the On-X representative, Catheran Burnett, at
[email protected] or phone 888-339-8000 x265